This article is more than 5 years old. Information may no longer be current.
NPF changes August observance to Psoriasis Action Month
The National Psoriasis Foundation announced it is changing its August observation of Psoriasis Awareness Month to Psoriasis Action Month.
The National Psoriasis Foundation (NPF) hosted the first Psoriasis Awareness Month 20 years ago as a public education initiative, according to a news release.
Since that time, with advancements in the number of treatment options available for people living with psoriasis, it’s easier to treat disease, according to NPF.
NPF reports that it wants patients with psoriasis to take an active role in treating their disease, and has created the theme of “Set Goals, Take Control,” for Psoriasis Action Month to focus on empowering patients.
The foundation is providing information and tools to set achievable treatment goals, track symptoms and help patients talk with their health care providers about treating psoriasis, according to the release. NPF has launched www.psoriasis.org/psoriasis-action-month, a website to educate patients, caregivers and health care professionals about the resources available to treat psoriatic disease.
Also, throughout August, patients with psoriasis can participate in interactive quizzes that will help them better understand and manage their disease, according to the release.
NPF also will host two Facebook Live interviews. The first, to be held Aug. 10, will be a discussion between Michael Siegel, NPF vice president of research programs, and April Armstrong MD, NPF medical board member and associate dean of Clinical Research at the Keck School of Medicine at the University of Southern California. They will discuss setting achievable treatment goals using a specific treatment strategy spearheaded by the NPF medical board, according to the release.
The second Facebook Live interview is scheduled for Aug. 24, as a discussion between Siegel, NPF volunteer Howard Chang, and his physician, Emanuel Maverakis, MD, associate professor at the University of California, Davis. The focus will be on how Chang and Maverakis are tracking Chang’s psoriasis after utilizing the treatment strategy that will be discussed with Armstrong.
Reference: www.psoriasis.org